|
1) 第1回心疾患 - 脳血管疾患死亡統計 人口動態統計特殊報告. 2007
|
|
|
|
|
2) National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcomes Quality Initiative. Am J Kidney Dis. 2002; 39(suppl 2): S1-266
|
|
|
|
|
|
3) Levey AS, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcome(KDIGO). Kidney Int. 2005; 67: 2089-100
|
|
|
|
|
4) CKD診療ガイドライン. 東京: 東京医学社; 2007
|
|
|
|
|
|
5) Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol. 2002; 13(suppl): S37-40
|
|
|
|
|
|
6) 日本透析医学会, 編. わが国の慢性透析療法の現況(2006年12月31日現在). 東京: 日本透析医学会統計調査委員会; 2007
|
|
|
|
|
|
7) Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130: 461-70
|
|
|
|
|
|
8) Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006; 145: 247-54
|
|
|
|
|
|
9) Imai E, Horio M, Nitta K, et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2007; 11: 41-50
|
|
|
|
|
10) Imai E, Horio M, Iseki K, et al. Prevalence of chronic kidney disease(CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol. 2007; 11: 156-63
|
|
|
|
|
|
11) Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovasucular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001; 286: 421-6
|
|
|
|
|
|
12) Abramson JL, et al. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int. 2003; 64: 610-5
|
|
|
|
|
|
13) Sarnak MJ, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003; 108: 2154-69
|
|
|
|
|
|
14) Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351: 1296-305
|
|
|
|
|
|
15) de Zeeu WD, Remuzzi G, Parving HH, et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation. 2004; 110: 921-7
|
|
|
|
|
|
16) Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004; 164: 659-63
|
|
|
|
|
|
17) Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med. 2004; 351: 1285-95
|
|
|
|
|
|
18) Ninomiya T, Kiyohara Y, Kubo M, et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama Study. Kidney Int. 2005; 68: 228-36
|
|
|
|
|
|
19) Irie F, Iso H, Sairenchi T, et al. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int. 2006; 69: 1264-71
|
|
|
|
|
|
20) Nakayama M, Metoki H, Terawaki H, et al. Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population - the Ohasama study. Nephrol Dial Transplant. 2007; 22: 1910-5
|
|
|
|
|
|
21) Townsend RR. Stroke in chronic kidney disease: prevention and management. Clin J Am Soc Nephrol. 2008; 3 (suppl 1): S11-6
|
|
|
|
|
|
22) Elsayed EF, Tighiouart H, Weiner DE, et al. Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKD. Am J Kidney Dis. 2008; 52: 49-57
|
|
|
|
|
|
23) Raggi P, Kleerekoper M. Contribution of bone and mineral abnormalities to cardio-vascular disease in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2008; 3: 836-43
|
|
|
|
|
|
24) Ueda S, Yamagishi S, Kaida Y, et al. Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease. Nephrology. 2007; 12: 582-90
|
|
|
|
|
|
25) Weiner DE, Tighiouart H, Elsayed EF, et al. Inflammation and cardiovascular events in individuals with and without chronic kidney disease. Kidney Int. 2008; 73: 1406-12
|
|
|
|
|
|
26) Shinohara Y. Regional differences in incidence and management of stroke-Is there any difference between Western and Japanese guidelines on antiplatelet therapy？ Cerebrovasc Dis. 2006; 21(suppl 1): 17-24
|
|
|
|
|
|
27) Lazarus JM, Lowrie EG, Hampers CL, et al. Cardiovascular disease in uremic patients on hemodialysis. Kidney Int. 1975; (suppl 2): 7: 167-75
|
|
|
|
|
|
28) Degouler P, Legraim M, Reach I, et al. Mortality risk factors in patients treated by chronic hemodialysis. Nephron. 1982; 31: 103-10
|
|
|
|
|
|
29) Iseki K, Kawazoe N, Osawa A, et al. Survival analysis of dialysis patients in Okinawa, Japan. Kidney Int. 1993; 43: 404-9
|
|
|
|
|
|
30) Kawamura M, Fijimoto S, Hisanaga S, et al. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. Am J Kidney Dis. 1998; 31: 991-6
|
|
|
|
|